Journal of Bone and Joint Surgery · 2011 · 137 citations · 36 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryCost-utility AnalysisOrthopedicsPharmacoeconomic ModelingComplications Of ArthroplastyDecision-analytic ModelingHip ArthroplastyMarkov ModelingRevision ArthroplastyRevision Joint ReplacementComplications Of Revision ArthroplastyMarkov Cohort ModelingQuality-adjusted Life ExpectancyQuality-adjusted Life Year ModelingQuality-adjusted Life Year PerspectiveRevisionsSurgical Site MorbidityTreatment Modality Selection
BACKGROUND: Two-stage revisions of total hip arthroplasties complicated by chronic infection result in reinfection rates that are lower than those following single-stage revisions but may also result in increased surgical morbidity. Using a decision analysis, we compared single-stage and two-stage revisions to determine which treatment modality resulted in greater quality-adjusted life years (QALYs). METHODS: A review of the literature on the treatment of patients with an infection at the site of a total hip arthroplasty provided probabilities; utility values for common postoperative health states were determined in a previously published study. With these data, we conducted a Markov cohort simulation decision analysis. Sensitivity analysis validated the model, and comparisons were made in terms of QALYs. RESULTS: The twelve-month model favored direct-exchange revision over the two-stage approach, regardless of whether surgeon or patient-derived utilities were used (0.945 versus 0.896 and 0.897 versus 0.861 QALYs for the patient and surgeon models, respectively). Similar results were observed in a lifetime model with a ten-year life expectancy (7.853 versus 7.771, and 7.438 versus 7.362 QALYs, respectively). The findings were found to be robust in sensitivity analyses in which clinically relevant ranges of input variables were used. CONCLUSIONS: This analysis favored the direct-exchange arthroplasty over the two-stage approach. This study should be considered hypothesis-generating for future randomized controlled trials in which, ideally, health end points will be considered in addition to the eradication of infection.
36
The Epidemiology of Revision Total Hip Arthroplasty in the United States
Kevin J. Bozic, Steven M. Kurtz, Edmund Lau et al. · The Journal of Arthroplasty · 2009 · 1.3K citations